Gateway to the Mind

The microbiome is the strange invisible world of our non human selves. On and in all of us are hoards of microbes. Their impact on our physical health is becoming clear to science, but a controversial idea is emerging too – that gut bacteria could alter what happens in our brains.

In this final episode of the series BBC Science and Health correspondent James Gallagher examines a growing body of research into the gut as a gateway to the mind and why some scientists believe we could be o the cusp of a revolution in psychiatry that uses microbes to improve mental health.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    SkinBiotherapeutics Plc

    More articles like this

    SkinBiotherapeutics Plc

    Probiotics & Skin: the next big thing in beauty?

    If we look back just a couple of decades, many people had not even heard the term ‘probiotic’, but awareness of ‘friendly bacteria’ has been gradually increasing, mainly due to the increased amount of scientific research

    SkinBiotherapeutics Plc

    Skinbiotherapeutics PLC Notice of interim results

    Skinbiotherapeutics PLC (LON:SBTX), a life sciences company focused on skin health, will publish its interim results for the six months to 31 December 2017 on 21 February 2018.   SkinBioTherapeutics is a life science company focused on

    SkinBiotherapeutics Plc

    Skinbiotherapeutics Appointment of Joint Broker

    Skinbiotherapeutics PLC (LON:SBTX), a life science company focused on skin health, announced today the appointment of Northland Capital Partners to act as the Company’s Joint Corporate Broker, alongside Turner Pope Investments, with immediate effect.   Skinbiotherapeutics is

    SkinBiotherapeutics Plc

    SkinBioTherapeutics Notification of first patent grant

    SkinBioTherapeutics plc (LON:SBTX), a life science company focused on skin health, announces the granting of the first patent for its SkinBiotix® technology in Australia. The patent granted covers the use of specific probiotic bacteria and lysates in

    SkinBiotherapeutics Plc

    SkinBioTherapeutics PLC Notice of Results

    SkinBioTherapeutics PLC (LON:SBTX) a life science company focused on skin health, will publish its full year results for the year to 30 June 2017 on Thursday, 5 October 2017.   SkinBioTherapeutics is a life science company

    SkinBiotherapeutics Plc

    Cosmetics: The next microbiome frontier

    “Love your bacteria.” That’s the tagline for Yun Probiotherapy’s line of skin cosmetics directed at those who have acne or athlete’s foot or who just want to keep their skin looking healthy. Yun’s product line, now